AC
DNA icon

AXQ Capital’s Ginkgo Bioworks DNA Stock Holding History

AXQ Capital’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Buy
+26,477
New +$221K 0.03% 649
2026
Q1 		– Sell
-11,997
Closed -$99.7K – 1062
2025
Q4 		$99.7K Buy
+11,997
New +$129K 0.02% 652

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

AXQ Capital's DNA Position: Q2 2026 in Review

AXQ Capital opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 26,477 shares worth $262K. The stake represents 0.03% of the portfolio and ranks #649 among its holdings. This is a return to the name: AXQ Capital previously reported a position in DNA as recently as Q4 2025.

AXQ Capital first reported a position in DNA in Q4 2025 and has held it in 2 quarters since. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • AXQ Capital held 26,477 shares of Ginkgo Bioworks worth $262K as of Q2 2026.
  • Ginkgo Bioworks was a new AXQ Capital position in Q2 2026.
  • Ginkgo Bioworks made up 0.03% of AXQ Capital's portfolio in Q2 2026, its #649 holding.
  • AXQ Capital first reported a position in Ginkgo Bioworks in Q4 2025 and has held it in 2 quarters since.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.